Dogma Therapeutics Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 4

Dogma Therapeutics General Information

Description

Operator of a biotechnology platform intended to develop small molecule compound to lower cholesterol. The company's platform focuses on offering an orally-bioavailable small molecule PCSK9 inhibitor by strategically focusing on small molecule inhibitors, enabling clients to dramatically disrupt the health economics of PCSK9-based therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 4 Dana Road
  • Boxford, MA 01921
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dogma Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 00.00 Completed Startup
2. Early Stage VC (Series A) 01-Apr-2017 00.00 00.00 000.00 Completed Startup
1. Accelerator/Incubator 01-Jan-2017 $2M $2M Completed Startup
To view Dogma Therapeutics’s complete valuation and funding history, request access »

Dogma Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2 000,000 00.000000 00 000.00 000.00 00 000.00 000
Series A-1 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
To view Dogma Therapeutics’s complete cap table history, request access »

Dogma Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Brian Hubbard Ph.D Co-Founder & Chief Executive Officer
Doug Daniels Co-Founder
Virendar Kaushik Co-Founder
To view Dogma Therapeutics’s complete executive team members history, request access »

Dogma Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JMCR Partners Venture Capital Minority 000 0000 000000 0
Viva BioInnovator Accelerator/Incubator Minority 000 0000 000000 0
Daoyuan Capital Venture Capital Minority 000 0000 000000 0
Sprout Bioventures Venture Capital Minority 000 0000 000000 0
To view Dogma Therapeutics’s complete investors history, request access »